The SocietyMore than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS communityBecome an ERS member
Treatment of COVID-19 is heterogeneous across Europe and the world, and evidence for COVID-19 treatment is accumulating rapidly. There is therefore a need for rapid, evidence-based treatment recommendations and information on how best to improve outcomes for hospitalised patients with COVID-19. The new ERS guidelines provide the perfect opportunity to improve knowledge and promote evidence-based practice.
